Results of EGM
Summary by AI BETAClose X
24 March 2026
Chrysalis Investments Limited
("Chrysalis" or the "Company")
Results of EGM
The Company announces the results of voting on the resolutions at its Extraordinary General Meeting ("EGM") held at 13:00 Hrs on Tuesday, 24 March 2026.
Andrew Haining, Chairman of Chrysalis commented: "I would like to thank shareholders for their support for the revised strategy. The board will now implement an orderly realisation of the Company's assets, in a manner consistent with maximising the portfolio value over a three-year period."
|
ORDINARY RESOLUTIONS |
FOR |
AGAINST |
TOTAL VOTES |
TOTAL VOTES % OF ORDINARY SHARES IN ISSUE |
VOTES WITHHELD* |
||
|
Votes |
% |
Votes |
% |
||||
|
THAT, conditional on the passing of Resolution 2, the proposed New Investment Policy as described in Part 4 of the circular to Shareholders dated 20 February 2026 of which this notice forms part (the "Circular") be adopted as the investment policy of the Company with immediate effect and the Existing Investment Policy be and is hereby so replaced. |
288,631,464 |
97.93 |
6,099,826 |
2.07 |
288,636,027 |
59.66 |
401,140 |
|
SPECIAL RESOLUTIONS |
FOR |
AGAINST |
TOTAL VOTES |
TOTAL VOTES % OF ORDINARY SHARES IN ISSUE |
VOTES WITHHELD* |
||
|
Votes |
% |
Votes |
% |
||||
|
THAT, conditional on the passing of Resolution 1, the draft articles of incorporation produced to the meeting and signed by the Chairman for identification purposes be approved and adopted as the articles of incorporation of the Company in substitution for, and to the exclusion of, the existing articles of incorporation of the Company to take effect immediately. |
288,421,367 |
97.87 |
6,268,159 |
2.13 |
288,425,930 |
59.66 |
442,904
|
-ENDS-
|
For further information, please contact
Media Montfort Communications: Charlotte McMullen / Imogen Saunders |
+44 (0) 7921 881 800 chrysalis@montfort.london |
|
|
|
|
Investment Adviser Chrysalis Investment Partners LLP: James Simpson
|
+44 (0) 20 7871 5343 |
|
G10 Capital Limited (AIFM): |
+44 (0) 20 7397 5450 |
|
Maria Baldwin |
|
|
Barclays Bank PLC: Dion Di Miceli / Stuart Muress / James Atkinson
|
+44 (0) 20 7623 2323 |
|
Panmure Liberum: Chris Clarke / Darren Vickers
|
+44 (0) 20 3100 2222 |
|
Deutsche Numis: Nathan Brown / Matt Goss
|
+44 (0) 20 7260 1000 |
|
IQEQ Fund Services (Guernsey) Limited: Aimee Gontier / Elaine Smeja |
+44 (0) 1481 231852 |
LEI: 213800F9SQ753JQHSW24
A copy of this announcement will be available on the Company's website at https://www.chrysalisinvestments.co.uk
The information contained in this announcement regarding the Company's investments has been provided by the relevant underlying portfolio company and has not been independently verified by the Company. The information contained herein is unaudited.
This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.
The Company is an alternative investment fund ("AIF") for the purposes of the AIFM Directive and as such is required to have an investment manager who is duly authorised to undertake the role of an alternative investment fund manager ("AIFM"). The AIFM appointed is G10 Capital Limited (part of the IQEQ Group). Chrysalis Investment Partners LLP (FRN: 1009684) is an Appointed Representative of G10 Capital (FRN: 648953) Limited, which is authorised and regulated by the Financial Conduct Authority.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 21 minutes ago JPMorgan Emerging Markets Growth & Income plc
- 24 minutes ago National Grid
- 1 hour ago City of London Investment Group
- 1 hour ago BioPharma Credit
- 1 hour ago BioPharma Credit